{"name":"Terremoto Biosciences Inc.","slug":"terremoto-biosciences-inc","ticker":"","exchange":"","domain":"terremoto.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE4xMHVKU1RITHdrZjVaUW1md05BUnU3UzhLMG82YXJHUWtDYnpMTDFEU051UjVWVlFDLTcyb3dpQTZQcTVnempQbmM0ekhjeVBPVlp2NDJyMHl1QllIR3ZF?oc=5","date":"2026-01-13","type":"trial","source":"nature.com","summary":"Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson - nature.com","headline":"Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE9iVUFUYkF6aGt3akxZT0hGaW1LLTVITDlQdFFCYUZkc2IwaDJKSHZpQ1d2VmtPWldraV9yWm9idUZab0xqcWZzdXllQ1BIaF9WUGVxcFJMNWhPakFld2QzRVg2dElTbkZjVjdzcEY3QmtFRG96SzhTT25aMkY?oc=5","date":"2025-12-17","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech Layoff Tracker 2025: Voyager jettisons 30 staffers; Mythic and Areteia shutter - Fierce Biotech","headline":"Fierce Biotech Layoff Tracker 2025: Voyager jettisons 30 staffers; Mythic and Areteia shutter","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxPNTFEZXpqOEhWSTVqMDZfek40b21sSDByb3VTbnVRcjU1YkhLd3A5OUNPUkpZV1FRdDlPZG5kdEpGamdNS1FTaFAtTzZXYWtxT3d6UG1wNXY1OTlGRDFXdWhONnFTWDctaGRNZXAyZkJjTWsxZ0h1N3N3dExZaTNXaDF4NUJ5Zw?oc=5","date":"2025-08-20","type":"trial","source":"Oncology Pipeline","summary":"Astellas and Amgen join the pan-KRAS push | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline","headline":"Astellas and Amgen join the pan-KRAS push | ApexOnco - Clinical Trials news and analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQN2wzNFdHTDNla2x0M19VRTh3U3BPdzBjZGZIcU1XeWxlbnBMRzd4Q1N3U2dzcmNjS0tJMlFOa1N1YkxEWElaZWw4aFNLS2Y3MTY1LWdmUVdSaXdKdmc4cDY3WHNJSzFiSzNHbUx3SkpxUWtyVWYtMDQyUDJqSHVlYjcxb1VrcmVVc3FPXzRrZDc3Rmt0Wkp6cmFsSkwwMGl5U3UzS1k3d1hwZnBU?oc=5","date":"2025-06-27","type":"pipeline","source":"statnews.com","summary":"Proposed cuts could have ‘catastrophic effect,’ 110 biomedical, health sciences industry leaders tell Congress - statnews.com","headline":"Proposed cuts could have ‘catastrophic effect,’ 110 biomedical, health sciences industry leaders tell Congress","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE9sSFdmT3Zra1JhMDc4XzYzWGdFOHF6MGU2SzQyRU1GWDd3SEZzV29UMWNWUXBoVUsxTVZfU1UxdDBYLVBiNlJseTZiUU4tbUk5eGdkVnY0RmZtZTdqVGF2Sm5R?oc=5","date":"2025-04-10","type":"pipeline","source":"statnews.com","summary":"John Link, HIV/AIDs researcher, named to 2025 STATUS List - statnews.com","headline":"John Link, HIV/AIDs researcher, named to 2025 STATUS List","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPV0JlZHdTVWM5MVB3Q01uSGhTTU1IMEJaQ18xb1JrVlc1QkVnM3hKZ21xOGoxVmpnRTRod3ZhVlpJa0tWRHYyU2o5MGdHT1FrVmxrVlZLQkxSOER0T2xaNXFKNnplbUFLZlJFSTVtNkJrNVlDdFg4TksxeG5mYUd2a2ZVLVBHTTdodjIzZm5HSmQ5bllnUU1QZ2xyVlNWdw?oc=5","date":"2025-02-26","type":"patent","source":"BioWorld News","summary":"Terremoto Biosciences patents AKT1 inhibitors for cancer - BioWorld News","headline":"Terremoto Biosciences patents AKT1 inhibitors for cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNS0xJRzdqU1hkaEV3c1BzZHd3V1BvUjFoLWo3aW80SktGMWdNaFBJYkViTE9YbkNxcy03WjNTTU1XbTlVMkdHWWdmeXJobFZIcnVVZ1BlcVJPX2VWenhyV2J4dFdodTBWcDZOTklYNDBvMXpURnZMQnhLa2d5WmcwWkRoTU53Nnd4aGFsY1c2MTU0SmZrUDhQeU14VkRMeXRNdW5nVU9Xal9Sd1JFZGRlMU5CMzNNTGlZSGJuUzhvWQ?oc=5","date":"2024-05-10","type":"trial","source":"ascopost.com","summary":"Selective Targeting of PARP1 in Early-Phase Study Shows Activity in Breast Cancer - ascopost.com","headline":"Selective Targeting of PARP1 in Early-Phase Study Shows Activity in Breast Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxPeG8tRnI5WFBPM0VkR1FucXdqcXZBamxaTWJtM3pUYndpM2dvRkswZEl6bkpBS00yZERPbENGNURTaGQ3NFZMOXlsQ1JUUU9hQkU2Qmc4LXhaXzF3NmZmYUhEWEhNWDk2YWFXMHpkWEMtVzVGN1RFYmc1T0F6TGhFM0lRdkJRMEozcnZkM0ZXc21fNTJJcDJ5V29kNmZBQUZERnczNXl6LUVUcWRFSkNHeTJ6a1NlM1k3NEkw?oc=5","date":"2023-11-02","type":"pipeline","source":"Business Wire","summary":"Terremoto Biosciences Closes $175 Million Series B Financing - Business Wire","headline":"Terremoto Biosciences Closes $175 Million Series B Financing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxOQy1rVlZFUXZacE5lanIwbklBT1lpUzRGZ0xFdnZuQ0JRUnhZNS1BNWc1NXJEeFgyWng0SC12WnA5aWc3Ym9RT3BMeWE0RDFteUM4ekNQTVF1LUlXYUpiaEJ1SElBX2tWQnVZbEJ1cWZDbDdhYVN2ZFg5dl9renEyaGU2U25wc0RaekJOdzJiTF9yMk9EVDNJ?oc=5","date":"2022-07-28","type":"pipeline","source":"Business Insider","summary":"Meet the 23 biotech startups that are set to take off in the next 12 months, according to top VCs - Business Insider","headline":"Meet the 23 biotech startups that are set to take off in the next 12 months, according to top VCs","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}